Sun Pharmaceutical Industries Ltd. is talking with advisers about a possible bid for New York-listed wellness company Organon ...

Jan 23 () - Sun ​Pharmaceutical ‌Industries, India's ‌top drugmaker by ⁠revenue, ‌said on Friday ‍that it has ​received ‌regulatory approval to manufacture and sell ⁠generic ​semaglutide ​in India.

By Kashish Tandon and Rishika Sadam Jan 23 (Reuters) - Sun Pharmaceutical Industries, India's top drugmaker by revenue, said ...

India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE:OGN), a ...

India's top drug maker Sun Pharmaceutical Industries has announced today the launch of a generic version of semaglutide, the ...

By Rishika Sadam and Kashish Tandon Jan 23 (Reuters) - Indian drugmakers Sun Pharmaceutical Industries, Zydus Lifesciences ...

Sun Pharma receives DCGI approval to launch generic Wegovy semaglutide in India after patent expiry in March 2026. Check ...

Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the ...

The company has received approval from the Drugs Controller General of India (DCGI) to manufacture and market Semaglutide ...

Industry leaders in pharma and MedTech are urging the government to establish a structured funding framework for R&D ahead of ...

While Pakistan once dominated this space, border closures, repeated clashes and a Taliban-imposed ban have badly disrupted ...

Peethaambaran Kunnathoor, Chennai Saturday, January 24, 2026, 08:00 Hrs [IST] ...